Join our daily newsletter At The Bell to receive exclusive market insights
- Pro Medicus (PME) signs a seven-year, $28 million contract with Allina Health through its wholly-owned US subsidiary Visage Imaging
- Under the terms of the contract, the company’s Visage 7 Enterprise Imaging Platform and Visage 7 Workflow module will be implemented throughout the Allina Health network
- Planning for the rollout will commence immediately and will be based on Visage’s proven cloud native implementation process with initial go-lives targeted for the second half of 2022
- The contract also marks Pro Medicus’ continued rapid expansion into North American integrated delivery networks
- Shares in Pro Medicus were down 0.29 per cent to $41.17 at the close of trading on Thursday
Leading health imaging company Pro Medicus (PME) has signed a seven-year, $28 million contract with Allina Health through its wholly-owned US subsidiary Visage Imaging.
Under the terms of the contract, the company’s Visage 7 Enterprise Imaging Platform and Visage 7 Workflow module will be implemented throughout the Allina Health network, which will provide a unified diagnostic imaging platform across the network.
Planning for the rollout will commence immediately and will be based on Visage’s proven cloud native implementation process with initial go-lives targeted for the second half of 2022.
The contract also marks Pro Medicus’ continued rapid expansion into North American integrated delivery networks (IDN).
Pro Medicus CEO Dr Sam Hupert said this is the company’s fifth major contract in the North American integrated delivery network (IDN) in 18 months, underpinning the strong momentum building in the market.
“IDN’s are growing because of the trend towards value-based medicine coupled with industry consolidation,” Dr Hupert said.
“Our Visage 7 platform is ideally suited to meet their needs with its unparalleled speed, scalability, and proven cloud capability.”
Allina Health joins an increasing number of Visage clients to opt for a fully cloud-based solution, a trend that has taken a major foothold in the North American healthcare IT market.
“Our pipeline remains strong and spans a growing number of market segments, including academic institutions, the IDN space, independent radiology groups, and the for-profit sector,” Dr Hupert added.
“Our proven cloud-engineered technology provides us with a very significant strategic
advantage with the last six of our major contracts being cloud-based — a trend we think will continue.”
Shares in Pro Medicus were down 0.29 per cent to $41.17 at the close of trading on Thursday.
